|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 106, Issue 1 55-65, Copyright © 1993 by Company of Biologists
JOURNAL ARTICLES |
M Yamagata, S Saga, M Kato, M Bernfield and K Kimata
Institute for Molecular Science of Medicine, Aichi Medical University, Japan.
We showed previously that a large chondroitin sulfate proteoglycan, PG-M (also known as versican), inhibits cell-substratum adhesion, while basement membrane heparan sulfate proteoglycan (recently named perlecan) does not (Yamagata et al. (1989) J. Biol. Chem. 264, 8012-8018). To extend our understanding of the adhesive function of these proteoglycans, we examined the pericellular localization of the proteoglycans and their ligands and also that of some matrix receptors and cytoskeletal molecules in various fibroblast culture systems. PG-M was abundant in the subcellular space of fibroblasts, but was excluded selectively from focal contacts where vinculin, integrins and fibronectin were localized. Hyaluronan, CD44 and tenascin were distributed similarly as PG-M. In contrast, perlecan was associated with fibronectin and was included in focal contacts. Syndecan-1, a membrane heparan sulfate/chondroitin sulfate proteoglycan, was associated with fibronectin at the cell surface, partly at focal contacts and in association with stress fibers. Thus, complexes of PG-M with hyaluronan, tenascin and CD44, are not involved in focal contacts. On the other hand, perlecan and syndecan-1 together with fibronectin may participate in focal contacts. The difference in localization between these proteoglycans may be related to their glycosaminoglycan content and to their distinctive roles in cell-substratum adhesion.
This article has been cited by other articles:
![]() |
C. Ricciardelli, D. L. Russell, M. P. Ween, K. Mayne, S. Suwiwat, S. Byers, V. R. Marshall, W. D. Tilley, and D. J. Horsfall Formation of Hyaluronan- and Versican-rich Pericellular Matrix by Prostate Cancer Cells Promotes Cell Motility J. Biol. Chem., April 6, 2007; 282(14): 10814 - 10825. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumoto, N. Kamiya, K. Suwan, F. Atsumi, K. Shimizu, T. Shinomura, Y. Yamada, K. Kimata, and H. Watanabe Identification and Characterization of Versican/PG-M Aggregates in Cartilage J. Biol. Chem., June 30, 2006; 281(26): 18257 - 18263. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kamiya, H. Watanabe, H. Habuchi, H. Takagi, T. Shinomura, K. Shimizu, and K. Kimata Versican/PG-M Regulates Chondrogenesis as an Extracellular Matrix Molecule Crucial for Mesenchymal Condensation J. Biol. Chem., January 27, 2006; 281(4): 2390 - 2400. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamagata and J. R. Sanes Versican in the Developing Brain: Lamina-Specific Expression in Interneuronal Subsets and Role in Presynaptic Maturation J. Neurosci., September 14, 2005; 25(37): 8457 - 8467. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Casar, C. Cabello-Verrugio, H. Olguin, R. Aldunate, N. C. Inestrosa, and E. Brandan Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation J. Cell Sci., January 1, 2004; 117(1): 73 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumoto, M. Shionyu, M. Go, K. Shimizu, T. Shinomura, K. Kimata, and H. Watanabe Distinct Interaction of Versican/PG-M with Hyaluronan and Link Protein J. Biol. Chem., October 17, 2003; 278(42): 41205 - 41212. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Sakko, C. Ricciardelli, K. Mayne, S. Suwiwat, R. G. LeBaron, V. R. Marshall, W. D. Tilley, and D. J. Horsfall Modulation of Prostate Cancer Cell Attachment to Matrix by Versican Cancer Res., August 15, 2003; 63(16): 4786 - 4791. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takagi, Y. Asano, N. Yamakawa, I. Matsumoto, and K. Kimata Annexin 6 is a putative cell surface receptor for chondroitin sulfate chains J. Cell Sci., August 15, 2002; 115(16): 3309 - 3318. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ricciardelli, J. H. Brooks, S. Suwiwat, A. J. Sakko, K. Mayne, W. A. Raymond, R. Seshadri, R. G. LeBaron, and D. J. Horsfall Regulation of Stromal Versican Expression by Breast Cancer Cells and Importance to Relapse-free Survival in Patients with Node-negative Primary Breast Cancer Clin. Cancer Res., April 1, 2002; 8(4): 1054 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hirohata, L. W. Wang, M. Miyagi, L. Yan, M. F. Seldin, D. R. Keene, J. W. Crabb, and S. S. Apte Punctin, a Novel ADAMTS-like Molecule, ADAMTSL-1, in Extracellular Matrix J. Biol. Chem., March 29, 2002; 277(14): 12182 - 12189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lemire, K. R. Braun, P. Maurel, E. D. Kaplan, S. M. Schwartz, and T. N. Wight Versican/PG-M Isoforms in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1630 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kishimoto, R. Ehama, L. Wu, S. Jiang, N. Jiang, and R. E. Burgeson Selective activation of the versican promoter by epithelial- mesenchymal interactions during hair follicle development PNAS, June 22, 1999; 96(13): 7336 - 7341. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Evanko, J. C. Angello, and T. N. Wight Formation of Hyaluronan- and Versican-Rich Pericellular Matrix Is Required for Proliferation and Migration of Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 1004 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Belknap, M. C. M. Weiser-Evans, S. S. Grieshaber, R. A. Majack, and K. R. Stenmark Relationship between Perlecan and Tropoelastin Gene Expression and Cell Replication in the Developing Rat Pulmonary Vasculature Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 24 - 34. [Abstract] [Full Text] |
||||
![]() |
Y. Zhang, L. Cao, C. G. Kiani, B. L. Yang, and B. B. Yang The G3 Domain of Versican Inhibits Mesenchymal Chondrogenesis via the Epidermal Growth Factor-like Motifs J. Biol. Chem., December 4, 1998; 273(49): 33054 - 33063. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Henderson and A. J. Copp Versican Expression Is Associated With Chamber Specification, Septation, and Valvulogenesis in the Developing Mouse Heart Circ. Res., September 7, 1998; 83(5): 523 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, L. Cao, B. L. Yang, and B. B. Yang The G3 Domain of Versican Enhances Cell Proliferation via Epidermial Growth Factor-like Motifs J. Biol. Chem., August 14, 1998; 273(33): 21342 - 21351. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Koyama, M. G. Kinsella, T. N. Wight, U. Hedin, and A. W. Clowes Heparan Sulfate Proteoglycans Mediate a Potent Inhibitory Signal for Migration of Vascular Smooth Muscle Cells Circ. Res., August 10, 1998; 83(3): 305 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Iida, A. M. L. Meijne, T. R. Oegema Jr., T. A. Yednock, N. L. Kovach, L. T. Furcht, and J. B. McCarthy A Role of Chondroitin Sulfate Glycosaminoglycan Binding Site in alpha 4beta 1 Integrin-mediated Melanoma Cell Adhesion J. Biol. Chem., March 6, 1998; 273(10): 5955 - 5962. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stigson, J. Lofberg, and L. Kjellen PG-M/Versican-like Proteoglycans Are Components of Large Disulfide-stabilized Complexes in the Axolotl Embryo J. Biol. Chem., February 7, 1997; 272(6): 3246 - 3253. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chung and H. Erickson Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C J. Cell Sci., January 6, 1997; 110(12): 1413 - 1419. [Abstract] [PDF] |
||||
![]() |
J. M. Lemire, S. Potter-Perigo, K. L. Hall, T. N. Wight, and S. M. Schwartz Distinct Rat Aortic Smooth Muscle Cells Differ in Versican/PG-M Expression Arterioscler. Thromb. Vasc. Biol., June 1, 1996; 16(6): 821 - 829. [Abstract] [Full Text] |
||||
![]() |
N. Itano and K. Kimata Expression Cloning and Molecular Characterization of HAS Protein, a Eukaryotic Hyaluronan Synthase J. Biol. Chem., April 26, 1996; 271(17): 9875 - 9878. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zako, T. Shinomura, M. Ujita, K. Ito, and K. Kimata Expression of PG-M(V3), an Alternatively Spliced Form of PG-M without a Chondroitin Sulfate Attachment Region in Mouse and Human Tissues J. Biol. Chem., February 24, 1995; 270(8): 3914 - 3918. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, T. Shinomura, M. Zako, M. Ujita, and K. Kimata Multiple Forms of Mouse PG-M, a Large Chondroitin Sulfate Proteoglycan Generated by Alternative Splicing J. Biol. Chem., January 13, 1995; 270(2): 958 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Landolt, L Vaughan, K. Winterhalter, and D. Zimmermann Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth Development, January 8, 1995; 121(8): 2303 - 2312. [Abstract] [PDF] |
||||
![]() |
M Yamagata and K Kimata Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican J. Cell Sci., January 9, 1994; 107(9): 2581 - 2590. [Abstract] [PDF] |
||||